By comparing cancer tissues from different sources, Sabine’s team found that ITPKA expression was higher in lung adenocarcinoma, correlated with poor clinical and pathological staging in patients, and predicted poor survival outcomes in these patients [23], all of which could be verified in online open databases (Figure 1). The gene discussed is ITPKA; the disease is lung adenocarcinoma.